Swiss drugmaker Novartis announced this week that it is acquiring The Medicines Co in a $9.7 billion takeover. Novartis is paying $85 per share in cash, a 24% premium over The Medicines Co’s closing price of $68.55 this past Friday. Novartis plans to pay for with one-third cash and two-thirds long-term borrowings. The company is … Continue reading “Novartis to Acquire Heart Drug Maker The Medicines Co”
